Latest Breaking News On - லி கா ஷிங் பயன்படுத்தப்பட்டது வைராலஜி நிறுவனம் - Page 1 : comparemela.com

 E-Mail A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for discovering the hepatitis C virus (HCV) in 1989. Sir Michael will discuss the development of a vaccine in a special presentation at this year s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), held online this year. Up to 2 million new HCV infections occur every year around the world, with an estimated 70 million carriers of the virus globally, most of whom are not diagnosed. The virus is estimated to cause some 400,000 deaths annually. Many infected with the virus go on to develop liver cirrhosis and liver cancer.

Michael houghtonUniversity of albertaEuropean congressLi ka shing applied virology instituteOxford universityProfessor sir michael houghtonNobel prizeClinical microbiologyInfectious diseasesSir michaelமைக்கேல் ஹ ought க்டன்பல்கலைக்கழகம் ஆஃப் ஆல்பர்ட்டாஐரோப்பிய காங்கிரஸ்லி கா ஷிங் பயன்படுத்தப்பட்டது வைராலஜி நிறுவனம்ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம்நோபல் ப்ரைஸ்